Skip to NavigationSkip to content

News

Scientists in the US have reported findings suggesting that certain molecules in the blood are strongly associated with complications during birth,...
Allergan announced in Q3 results that it's ready to sell Teva's shares, after the value crashed over the last year due to Teva's difficulties.
Only yesterday it was revealed that Novartis had applied to the FDA in the same indication that Gilead’s treatment is approved in, today it revealed...
In a rare spot of good news for Tecentriq, after a turbulent period, Roche’s drug has been given the nod by NICE to be funded through the Cancer Drug...
An experimental drug from Indivior which is designed to treat opioid addiction has been recommended by an advisory panel to the FDA, meaning full...
A group of states, 45 members-strong, has expanded its probe into the generics pharmaceutical industry by expanding its case to include 18 companies...
AstraZeneca and MedImmune, the company’s global biologics research and development arm, have announced new Phase 3 data revealing that tralokinumab...
Figures released by NHS Scotland have revealed that the numbers of deaths from cancer are 67% higher in the poorest areas of the country.
Shire has revealed that it plans to sell one of its manufacturing sites in Milford, Massachusetts, as well as bringing some production of its...
New data on Fortasyn Connect – also known as Souvenaid – an over-the-counter multinutrient drink which claims to be able to delay the development of...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches